RT Journal Article
SR Electronic
T1 Post-COVID-19 syndrome: retinal microcirculation as a potential marker for chronic fatigue
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.23.22280264
DO 10.1101/2022.09.23.22280264
A1 Sarah Schlick
A1 Marianna Lucio
A1 Alexander Bartsch
A1 Adam Skornia
A1 Jakob Hoffmanns
A1 Charlotte Szewczykowski
A1 Thora Schröder
A1 Franziska Raith
A1 Lennart Rogge
A1 Felix Heltmann
A1 Michael Moritz
A1 Lorenz Beitlich
A1 Julia Schottenhamml
A1 Martin Herrmann
A1 Thomas Harrer
A1 Marion Ganslmayer
A1 Friedrich E. Kruse
A1 Robert Lämmer
A1 Christian Mardin
A1 Bettina Hohberger
YR 2022
UL http://medrxiv.org/content/early/2022/09/23/2022.09.23.22280264.abstract
AB Post-COVID-19 syndrome (PCS) summarizes persisting sequelae after infection with the severe-acute-respiratory-syndrome-Coronavirus-2 (SARS-CoV-2). PCS can affect patients of all covid-19 disease severities. As previous studies revealed impaired blood flow as a provoking factor for triggering PCS, it was the aim of the present study to investigate a potential association of self-reported chronic fatigue and retinal microcirculation in patients with PCS, potentially indicating an objective biomarker.A prospective study was performed, including 201 subjects: 173 patients with PCS and 28 controls. Retinal microcirculation was visualized by OCT-Angiography (OCT-A) and quantified by the Erlangen-Angio-Tool as macula and peripapillary vessel density (VD). Chronic Fatigue (CF) was assessed with the variables ‘Bell score’, age and gender. The VD in the superficial vascular plexus (SVP), intermediate capillary plexus (ICP) and deep capillary plexus (DCP) were analyzed considering the repetitions (12 times). Taking in account of such repetitions a mixed model was performed to detect possible differences in the least square means between different groups of analysis.An age effect on VD was observed between patients and controls (p<0.0001). Gender analysis yielded that women with PCS showed lower VD levels in SVP compared to male patients (p=0.0015). The PCS patients showed significantly lower VD of ICP as compared to the controls (p=0.0001, [CI: 0.32; 1]). Moreover, considering PCS patients, the mixed model reveals a significant difference between chronic fatigue (CF) and without CF in VD of SVP (p=0.0033, [CI: -4.5; -0.92]). The model included age, gender and the variable ‘Bell score’, representing a subjective marker for CF. Consequently, the retinal microcirculation might be an objective biomarker in subjective-reported chronic fatigue of patients with PCS.Competing Interest StatementThe authors declare no conflict of interest in the present topic of the study. Hohberger B (Heidelberg Engineering), Harrer T (none), Kruse F (none), Hoffmanns J (none), Rogge L (none), Heltmann F (none), Moritz M (none), Beitlich L (none), Lucio M (none), Schlick S (none), Schottenhamml J (none), Laemmer R (none), Herrmann M (none), Mardin C (Heidelberg Engineering), Skornia A (none), Bartsch A (none).Funding StatementThe present study was funded by Bavarian Health and Food Safety Authority (LGL; 2490-PC-2021-V14): Discover – Establishment and evaluation of a clinical algorithms for an objective diagnosis of subtypes of Long–COVID as essential basis for an effective patients care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The studies involving human participants were reviewed and approved by the ethics committee of the University of Erlangen-Nuernberg (295_20 B). The patients/participants provided their written informed consent to participate in this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors